Your browser doesn't support javascript.
loading
Importance of family planning in patients with immune-mediated inflammatory diseases: a multidisciplinary approach. / Importancia de la planificación familiar en pacientes con enfermedades inflamatorias inmunomediadas: un abordaje multidisciplinar.
Martínez-Barrio, Julia; Martínez López, Juan Antonio; Galindo, María; Ais, Arantza; Martínez Sánchez, Nuria; Cano, Laura.
Afiliação
  • Martínez-Barrio J; Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, España. Electronic address: juliamartinezbarrio@gmail.com.
  • Martínez López JA; Servicio de Reumatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
  • Galindo M; Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España.
  • Ais A; Servicio de Farmacia Hospitalaria, Hospital Universitario Gregorio Marañón, Madrid, España.
  • Martínez Sánchez N; Consulta de Enfermedades Autoinmunes y Embarazo, Unidad de Tocología de Alto Riesgo y Obstetricia Médica, Servicio de Obstetricia y Ginecología, Hospital Universitario La Paz, Madrid, España.
  • Cano L; Unidad de Gestión Clínica (UGC) Reumatología, Hospital Regional Universitario de Málaga, Málaga, España.
Article em En, Es | MEDLINE | ID: mdl-33483261
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Family planning in women with immune-mediated inflammatory diseases is a challenge for healthcare teams, highlighting the need for standardized available evidence to provide patients with objective and agreed information. This study reflects the work performed by a multidisciplinary team in reviewing available scientific evidence, and the strategy agreed for family planning, pregnancy, postpartum, and breastfeeding in patients with immune-mediated inflammatory diseases.

METHODS:

A literature search was conducted, information was structured across the different stages (preconception, pregnancy, postpartum and breastfeeding), and an on-site meeting was convened, in which patients and healthcare providers participated.

RESULTS:

Specific materials, which are included in this work, were developed to guide clinical decisions to be agreed upon by patients and healthcare providers.

CONCLUSION:

These materials meet the need for validated and updated information on the approach and use of indicated drugs for professionals responsible for the management of immune-mediated inflammatory diseases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En / Es Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En / Es Ano de publicação: 2021 Tipo de documento: Article